Reply to: Sustained resolutin of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy

被引：1
|
作者：
Gopal, Deepak V. [1 ]
Rosen, Hugo R.
机构：
[1] Univ Wisconsin, Div Gastroenterol & Hepatol, Madison, WI 53706 USA
[2] Univ Colorado, Div Gastroenterol & Hepatol, Denver, CO 80202 USA
[3] Univ Colorado, Hepatitis C Res Ctr, Denver, CO 80202 USA
来源：
LIVER TRANSPLANTATION | 2007年 / 13卷 / 02期
关键词：
D O I：
10.1002/lt.21055
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [31] MENOPAUSE IS ASSOCIATED WITH RELAPSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Stern, Christiane
    Martinot-Peignoux, Michelle
    Ripault, Marie-Pierre
    Boyer, Nathalie
    Cardoso, Ana Carolina
    El Ray, Ahmed
    Asselah, Tarik
    Valla, Dominique
    Marcellin, Patrick
    HEPATOLOGY, 2010, 52 (04) : 788A - 788A
  • [32] Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin
    Kim, Ei Tae
    Kim, Lee Hoo
    Lee, Jung Il
    Chin, Hee Seung
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (06) : 598 - 602
  • [33] Cognitive function in hepatitis C patients: effect of pegylated interferon a and ribavirin therapy
    Abd el Meguid, M.
    Moussa, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S311 - S312
  • [34] Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation -: Response to interferon-α therapy.
    Toth, CM
    Pascual, M
    Chung, RT
    Graeme-Cook, F
    Dienstag, JL
    Bhan, AK
    Cosimi, AB
    TRANSPLANTATION, 1998, 66 (09) : 1254 - 1258
  • [35] Rapid Virologic Response Predicts Sustained Virologic Response in Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin Therapy
    Sarwar, Shahzad
    Iqbal, Masood
    McCormick, P. Aiden
    O'Farrelly, Cliona
    Hegarty, John E.
    GASTROENTEROLOGY, 2009, 136 (05) : A836 - A837
  • [36] Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation
    Fernandez, Inmaculada
    Meneu, Juan Carlos
    Colina, Francisco
    Garcia, Ignacio
    Munoz, Raquel
    Castellano, Gregorio
    Fuertes, Antonio
    Abradelo, Manuel
    Lumbreras, Carlos
    Moreno, Enrique
    Antonio Solis-Herruzo, Jose
    LIVER TRANSPLANTATION, 2006, 12 (12) : 1805 - 1812
  • [37] Sustained dysfunction of dendritic cells as a predictor for relapse in chronic hepatitis C patients who underwent 48-week pegylated interferon-α and ribavirin therapy
    Kanto, Tatsuya
    Itose, Ichiyo
    Inoue, Michiyo
    Miyazaki, Masanori
    Miyatake, Hideki
    Sakakibara, Mitsuru
    Yakushijin, Takayuki
    Oze, Tsugiko
    Hiramatsu, Naoki
    Takehara, Tetsuo
    Kasahara, Akinori
    Hayashi, Norio
    HEPATOLOGY, 2006, 44 (04) : 221A - 222A
  • [38] Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
    Gamal, Nesrine
    Brodosi, Lucia
    Misciali, Cosimo
    Patrizi, Annalisa
    Vukatana, Gentiana
    Malavolta, Nazzarena
    Bernardi, Mauro
    Andreone, Pietro
    ANNALS OF HEPATOLOGY, 2014, 13 (02) : 293 - 296
  • [39] Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C
    Martinot-Peignoux, M.
    Comanor, L.
    Minor, J. M.
    Ripault, M. P.
    Pham, B. -N.
    Boyer, N.
    Castelnau, C.
    Giuily, N.
    Hendricks, D.
    Marcellin, Patrick
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (10) : 701 - 707
  • [40] On Treatment Weight Loss as a Predictor of Sustained Virological Response During Pegylated Interferon and Ribavirin Therapy for Chronic Hepatitis C
    Dhavaleshwar, Deepti
    Babich, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S108 - S108
12345